Story perspectives

Supreme Court Restores Mifepristone Mail Access, Lawsuits Pending

5/26/2026

Summary

Story summary

The Supreme Court restored nationwide telemedicine and mail distribution of the abortion pill mifepristone after the Justice Department declined to defend the FDA’s policy, leaving lawsuits—including Louisiana’s—pending.
President Donald Trump’s administration refused to defend the FDA’s mail-order abortion-pill policy, leaving reproductive-health access in legal limbo.
Abortion rates have risen slightly since Roe v. Wade was overturned, largely because mifepristone is more accessible.

1 of 1

Story summary

The Supreme Court restored nationwide telemedicine and mail distribution of the abortion pill mifepristone after the Justice Department declined to defend the FDA’s policy, leaving lawsuits—including Louisiana’s—pending.
President Donald Trump’s administration refused to defend the FDA’s mail-order abortion-pill policy, leaving reproductive-health access in legal limbo.
Abortion rates have risen slightly since Roe v. Wade was overturned, largely because mifepristone is more accessible.